Drug Repurposing Analysis Report - asthma

📊 Analysis Overview

14
Total Candidate Drugs
0.841
Average Predicted Score
0.874
Highest Predicted Score
0
Known Drugs

🏆 Top 14 Candidate Drugs

ID Name pvalue rank Score # Shared Genes Paths Existing # Overlap Pathways Overlap Pathways Key Genes # Key Genes Degree # Shared Genes Shared Gene Names # Shared Diseases Shared Disease Names
DrugBank:DB00184 NICOTINE 0.00141 22 0.874 13 BDNF;AVP;CD8A;MMP1;PTGS2;CRP;MMP9;MMP2;Tnf;Il6;Ptgs2;Mmp9;Sirt1 No 132 AGE-RAGE signaling pathway in diabetic complications;AMPK signaling pathway;Acute myeloid leukemia;Adipocytokine signaling pathway;African trypanosomiasis;Allograft rejection;Alzheimer disease;Amoebiasis;Antigen processing and presentation;Apelin signaling pathway;Apoptosis;Arachidonic acid metabolism;Autophagy;B cell receptor signaling pathway;Bladder cancer;Breast cancer;C-type lectin receptor signaling pathway;Cellular senescence;Central carbon metabolism in cancer;Chagas disease;Chemical carcinogenesis;Chemokine signaling pathway;Chronic myeloid leukemia;Cocaine addiction;Colorectal cancer;Complement and coagulation cascades;Coronavirus disease;Cytokine-cytokine receptor interaction;Cytosolic DNA-sensing pathway;Diabetic cardiomyopathy;Endometrial cancer;Epstein-Barr virus infection;Estrogen signaling pathway;Fc epsilon RI signaling pathway;Fluid shear stress and atherosclerosis;Focal adhesion;FoxO signaling pathway;Gastric cancer;Glioma;Graft-versus-host disease;Growth hormone synthesis, secretion and action;HIF-1 signaling pathway;Hematopoietic cell lineage;Hepatitis B;Hepatitis C;Hepatocellular carcinoma;Herpes simplex virus 1 infection;Hippo signaling pathway;Human T-cell leukemia virus 1 infection;Human cytomegalovirus infection;Human immunodeficiency virus 1 infection;Human papillomavirus infection;Hypertrophic cardiomyopathy;IL-17 signaling pathway;Inflammatory bowel disease;Inflammatory mediator regulation of TRP channels;Influenza A;Insulin resistance;JAK-STAT signaling pathway;Kaposi sarcoma-associated herpesvirus infection;Legionellosis;Leishmaniasis;Leukocyte transendothelial migration;Lipid and atherosclerosis;Longevity regulating pathway;MAPK signaling pathway;Malaria;Measles;Melanoma;MicroRNAs in cancer;Mitophagy;NF-kappa B signaling pathway;NOD-like receptor signaling pathway;Natural killer cell mediated cytotoxicity;Necroptosis;Neuroactive ligand-receptor interaction;Neurotrophin signaling pathway;Neutrophil extracellular trap formation;Non-alcoholic fatty liver disease;Non-small cell lung cancer;Osteoclast differentiation;Ovarian steroidogenesis;Oxytocin signaling pathway;PD-L1 expression and PD-1 checkpoint pathway in cancer;PI3K-Akt signaling pathway;Pancreatic cancer;Pathogenic Escherichia coli infection;Pathways in cancer;Pathways of neurodegeneration;Pertussis;Phospholipase D signaling pathway;Platelet activation;Prion disease;Prolactin signaling pathway;Prostate cancer;Proteoglycans in cancer;RIG-I-like receptor signaling pathway;Rap1 signaling pathway;Ras signaling pathway;Regulation of actin cytoskeleton;Regulation of lipolysis in adipocytes;Relaxin signaling pathway;Renal cell carcinoma;Renin secretion;Rheumatoid arthritis;Salmonella infection;Serotonergic synapse;Shigellosis;Signaling pathways regulating pluripotency of stem cells;Small cell lung cancer;Sphingolipid signaling pathway;T cell receptor signaling pathway;TGF-beta signaling pathway;TNF signaling pathway;Th1 and Th2 cell differentiation;Th17 cell differentiation;Thyroid cancer;Thyroid hormone signaling pathway;Toll-like receptor signaling pathway;Toxoplasmosis;Transcriptional misregulation in cancer;Tuberculosis;Type I diabetes mellitus;Type II diabetes mellitus;VEGF signaling pathway;Viral carcinogenesis;Viral protein interaction with cytokine and cytokine receptor;Yersinia infection;cAMP signaling pathway;cGMP-PKG signaling pathway;mTOR signaling pathway;p53 signaling pathway BDNF 1 1784 14 COX2|MMP9|Il6|Sirt1|ELANE|CD8A|Mmp9|BDNF|MMP1|Tnf|CRP|AVP|PTGS2|MMP2|Ptgs2 6 osteoarthritis|Sepsis|respiratory failure|skin disorder|ulcerative colitis|ischemic disease
DrugBank:DB00368 NOREPINEPHRINE 0.00167 26 0.869 12 BDNF;AGT;AVP;CX3CL1;PTGS2;CRP;KCNMB2;Tnf;Il6;Nos2;Lep;Hif1a No 88 AGE-RAGE signaling pathway in diabetic complications;AMPK signaling pathway;Adipocytokine signaling pathway;African trypanosomiasis;Alzheimer disease;Amoebiasis;Arginine and proline metabolism;Arginine biosynthesis;Bladder cancer;C-type lectin receptor signaling pathway;Chagas disease;Chemical carcinogenesis;Cocaine addiction;Coronavirus disease;Cytokine-cytokine receptor interaction;Cytosolic DNA-sensing pathway;Estrogen signaling pathway;Fc epsilon RI signaling pathway;Fluid shear stress and atherosclerosis;FoxO signaling pathway;Graft-versus-host disease;Growth hormone synthesis, secretion and action;HIF-1 signaling pathway;Hematopoietic cell lineage;Hepatitis B;Human T-cell leukemia virus 1 infection;Human cytomegalovirus infection;Hypertrophic cardiomyopathy;IL-17 signaling pathway;Inflammatory bowel disease;Inflammatory mediator regulation of TRP channels;Influenza A;Insulin resistance;JAK-STAT signaling pathway;Kaposi sarcoma-associated herpesvirus infection;Legionellosis;Leishmaniasis;Lipid and atherosclerosis;Long-term depression;Longevity regulating pathway;MAPK signaling pathway;Malaria;Measles;NF-kappa B signaling pathway;NOD-like receptor signaling pathway;Necroptosis;Neuroactive ligand-receptor interaction;Non-alcoholic fatty liver disease;Osteoclast differentiation;Ovarian steroidogenesis;Oxytocin signaling pathway;PI3K-Akt signaling pathway;Pathogenic Escherichia coli infection;Pathways in cancer;Pathways of neurodegeneration;Pertussis;Phospholipase D signaling pathway;Prion disease;Prolactin signaling pathway;Prostate cancer;Proteoglycans in cancer;RIG-I-like receptor signaling pathway;Rap1 signaling pathway;Ras signaling pathway;Regulation of lipolysis in adipocytes;Relaxin signaling pathway;Renal cell carcinoma;Renin secretion;Renin-angiotensin system;Rheumatoid arthritis;Salmonella infection;Serotonergic synapse;Shigellosis;T cell receptor signaling pathway;TNF signaling pathway;Th17 cell differentiation;Toll-like receptor signaling pathway;Transcriptional misregulation in cancer;Tuberculosis;Type I diabetes mellitus;Type II diabetes mellitus;VEGF signaling pathway;Vascular smooth muscle contraction;Viral protein interaction with cytokine and cytokine receptor;Yersinia infection;cAMP signaling pathway;cGMP-PKG signaling pathway;mTOR signaling pathway AGT 1 1291 12 CX3CL1|Il6|F2|Hif1a|Nos2|Tnf|AGT|CRP|AVP|PTGS2|Lep|BDNF|KCNMB2 9 Fibrosis|Coronary Disease|atherosclerosis|heart disorder|cardiovascular disorder|Sepsis|myocardial infarction|diabetes mellitus|rheumatoid arthritis
MESH:D011453 Prostaglandins 0.00270 42 0.851 17 HSPA4;AGT;AVP;IL1A;VIP;PTGS2;IL10;PCLAF;COX1;Il6;Tgfb1;Ptgs2;Nos2;COX2;Il1b;Nfkb1;Ptgds No 119 AGE-RAGE signaling pathway in diabetic complications;Acute myeloid leukemia;Adipocytokine signaling pathway;African trypanosomiasis;Allograft rejection;Alzheimer disease;Amoebiasis;Antigen processing and presentation;Apoptosis;Arachidonic acid metabolism;Arginine and proline metabolism;Asthma;Autoimmune thyroid disease;B cell receptor signaling pathway;Bladder cancer;Breast cancer;C-type lectin receptor signaling pathway;Cellular senescence;Chagas disease;Chemical carcinogenesis;Chronic myeloid leukemia;Colorectal cancer;Coronavirus disease;Cytokine-cytokine receptor interaction;Cytosolic DNA-sensing pathway;Diabetic cardiomyopathy;Endometrial cancer;Epstein-Barr virus infection;Estrogen signaling pathway;Fc epsilon RI signaling pathway;Fluid shear stress and atherosclerosis;Focal adhesion;FoxO signaling pathway;Gastric cancer;Glioma;Graft-versus-host disease;Growth hormone synthesis, secretion and action;HIF-1 signaling pathway;Hematopoietic cell lineage;Hepatitis B;Hepatitis C;Hepatocellular carcinoma;Herpes simplex virus 1 infection;Human T-cell leukemia virus 1 infection;Human cytomegalovirus infection;Human papillomavirus infection;Hypertrophic cardiomyopathy;IL-17 signaling pathway;Inflammatory bowel disease;Inflammatory mediator regulation of TRP channels;Influenza A;Insulin resistance;Intestinal immune network for IgA production;JAK-STAT signaling pathway;Kaposi sarcoma-associated herpesvirus infection;Legionellosis;Leishmaniasis;Lipid and atherosclerosis;Long-term depression;Longevity regulating pathway;MAPK signaling pathway;Malaria;Measles;Melanoma;MicroRNAs in cancer;NF-kappa B signaling pathway;NOD-like receptor signaling pathway;Necroptosis;Neuroactive ligand-receptor interaction;Non-alcoholic fatty liver disease;Non-small cell lung cancer;Osteoclast differentiation;Ovarian steroidogenesis;Oxytocin signaling pathway;PD-L1 expression and PD-1 checkpoint pathway in cancer;PI3K-Akt signaling pathway;Pancreatic cancer;Pathogenic Escherichia coli infection;Pathways in cancer;Pathways of neurodegeneration;Pertussis;Phospholipase D signaling pathway;Platelet activation;Prion disease;Prolactin signaling pathway;Prostate cancer;Proteoglycans in cancer;RIG-I-like receptor signaling pathway;Rap1 signaling pathway;Ras signaling pathway;Regulation of actin cytoskeleton;Regulation of lipolysis in adipocytes;Relaxin signaling pathway;Renal cell carcinoma;Renin secretion;Renin-angiotensin system;Rheumatoid arthritis;Salmonella infection;Serotonergic synapse;Small cell lung cancer;Sphingolipid signaling pathway;T cell receptor signaling pathway;TGF-beta signaling pathway;TNF signaling pathway;Th1 and Th2 cell differentiation;Th17 cell differentiation;Toll-like receptor signaling pathway;Toxoplasmosis;Transcriptional misregulation in cancer;Tuberculosis;Type I diabetes mellitus;Type II diabetes mellitus;VEGF signaling pathway;Vascular smooth muscle contraction;Viral protein interaction with cytokine and cytokine receptor;Yersinia infection;cAMP signaling pathway;cGMP-PKG signaling pathway;mTOR signaling pathway PTGS2 1 212 17 COX2|Il6|IL10|Tgfb1|COX1|VIP|F2|AVP|PCLAF|Nos2|Il1b|AGT|Ptgds|HSPA4|PTGS2|IL1A|Nfkb1|Ptgs2 12 seasonal allergic rhinitis|Fibrosis|endometriosis|lung disorder|osteoarthritis|heart disorder|cardiovascular disorder|hypertensive disorder|status asthmaticus|diabetes mellitus|ischemic disease|rheumatoid arthritis
DrugBank:DB04630 ALDOSTERONE 0.00309 48 0.846 13 AGT;AVP;NR3C1;IL1A;VIP;CRP;MMP9;ADIPOQ;TIMP1;Il6;Nr3c1;Ccn2;Timp1 No 105 AGE-RAGE signaling pathway in diabetic complications;AMPK signaling pathway;Adipocytokine signaling pathway;African trypanosomiasis;Alzheimer disease;Amoebiasis;Apelin signaling pathway;Bladder cancer;Breast cancer;C-type lectin receptor signaling pathway;Cellular senescence;Central carbon metabolism in cancer;Chagas disease;Chemical carcinogenesis;Chronic myeloid leukemia;Colorectal cancer;Coronavirus disease;Cytokine-cytokine receptor interaction;Diabetic cardiomyopathy;Endometrial cancer;Epstein-Barr virus infection;Estrogen signaling pathway;Fc epsilon RI signaling pathway;Fluid shear stress and atherosclerosis;Focal adhesion;FoxO signaling pathway;Gastric cancer;Glioma;Graft-versus-host disease;Growth hormone synthesis, secretion and action;HIF-1 signaling pathway;Hematopoietic cell lineage;Hepatitis B;Hepatitis C;Hepatocellular carcinoma;Hippo signaling pathway;Human T-cell leukemia virus 1 infection;Human cytomegalovirus infection;Human immunodeficiency virus 1 infection;Human papillomavirus infection;Hypertrophic cardiomyopathy;IL-17 signaling pathway;Inflammatory bowel disease;Inflammatory mediator regulation of TRP channels;Influenza A;Insulin resistance;Intestinal immune network for IgA production;JAK-STAT signaling pathway;Kaposi sarcoma-associated herpesvirus infection;Leishmaniasis;Leukocyte transendothelial migration;Lipid and atherosclerosis;Long-term depression;Longevity regulating pathway;MAPK signaling pathway;Malaria;Melanoma;MicroRNAs in cancer;NOD-like receptor signaling pathway;Natural killer cell mediated cytotoxicity;Necroptosis;Neuroactive ligand-receptor interaction;Neurotrophin signaling pathway;Non-alcoholic fatty liver disease;Non-small cell lung cancer;Osteoclast differentiation;Ovarian steroidogenesis;Oxytocin signaling pathway;PD-L1 expression and PD-1 checkpoint pathway in cancer;PI3K-Akt signaling pathway;Pancreatic cancer;Pathways in cancer;Pathways of neurodegeneration;Pertussis;Phospholipase D signaling pathway;Prolactin signaling pathway;Prostate cancer;Proteoglycans in cancer;Rap1 signaling pathway;Ras signaling pathway;Regulation of actin cytoskeleton;Regulation of lipolysis in adipocytes;Relaxin signaling pathway;Renal cell carcinoma;Renin secretion;Renin-angiotensin system;Rheumatoid arthritis;Serotonergic synapse;Sphingolipid signaling pathway;TGF-beta signaling pathway;TNF signaling pathway;Th17 cell differentiation;Thyroid cancer;Toll-like receptor signaling pathway;Transcriptional misregulation in cancer;Tuberculosis;Type I diabetes mellitus;Type II diabetes mellitus;VEGF signaling pathway;Vascular smooth muscle contraction;Yersinia infection;cAMP signaling pathway;cGMP-PKG signaling pathway;mTOR signaling pathway;p53 signaling pathway AGT 1 1455 14 MMP9|Il6|Nr3c1|Ccn2|NR3C1|VIP|ADIPOQ|AGT|Timp1|CRP|AVP|TIMP1|IL1A|FPR1 6 Fibrosis|myocardial infarction|hypertensive disorder|kidney disorder|chronic kidney disease|diabetes mellitus
DrugBank:DB01050 IBUPROFEN 0.00315 49 0.846 5 IL1A;PTGS2;Tnf;COX1;COX2 No 84 AGE-RAGE signaling pathway in diabetic complications;Adipocytokine signaling pathway;African trypanosomiasis;Allograft rejection;Alzheimer disease;Amoebiasis;Antigen processing and presentation;Apoptosis;Arachidonic acid metabolism;C-type lectin receptor signaling pathway;Cellular senescence;Chagas disease;Chemical carcinogenesis;Chronic myeloid leukemia;Colorectal cancer;Complement and coagulation cascades;Coronavirus disease;Cytokine-cytokine receptor interaction;Cytosolic DNA-sensing pathway;Diabetic cardiomyopathy;Epstein-Barr virus infection;Fluid shear stress and atherosclerosis;Gastric cancer;Graft-versus-host disease;HIF-1 signaling pathway;Hematopoietic cell lineage;Hepatitis B;Hepatitis C;Herpes simplex virus 1 infection;Human T-cell leukemia virus 1 infection;Human cytomegalovirus infection;Human immunodeficiency virus 1 infection;Human papillomavirus infection;Hypertrophic cardiomyopathy;IL-17 signaling pathway;Inflammatory bowel disease;Inflammatory mediator regulation of TRP channels;Influenza A;Insulin resistance;JAK-STAT signaling pathway;Kaposi sarcoma-associated herpesvirus infection;Legionellosis;Leishmaniasis;Lipid and atherosclerosis;MAPK signaling pathway;Malaria;Measles;MicroRNAs in cancer;NF-kappa B signaling pathway;NOD-like receptor signaling pathway;Necroptosis;Non-alcoholic fatty liver disease;Osteoclast differentiation;Ovarian steroidogenesis;PD-L1 expression and PD-1 checkpoint pathway in cancer;PI3K-Akt signaling pathway;Pancreatic cancer;Pathogenic Escherichia coli infection;Pathways in cancer;Pathways of neurodegeneration;Pertussis;Prion disease;Prostate cancer;RIG-I-like receptor signaling pathway;Regulation of lipolysis in adipocytes;Rheumatoid arthritis;Salmonella infection;Serotonergic synapse;Shigellosis;Small cell lung cancer;Sphingolipid signaling pathway;T cell receptor signaling pathway;TNF signaling pathway;Th1 and Th2 cell differentiation;Th17 cell differentiation;Toll-like receptor signaling pathway;Toxoplasmosis;Transcriptional misregulation in cancer;Tuberculosis;Type I diabetes mellitus;Viral protein interaction with cytokine and cytokine receptor;Yersinia infection;cAMP signaling pathway;p53 signaling pathway PTGS2 1 2370 5 COX2|COX1|Tnf|PTGS2|IL1A 11 urticaria|Fibrosis|Inflammation|lung disorder|osteoarthritis|systemic lupus erythematosus|Sepsis|arthritic joint disease|skin disorder|ischemic disease|rheumatoid arthritis
DrugBank:DB00328 INDOMETHACIN 0.00328 51 0.845 25 AGT;AVP;IL1A;MPO;SELL;MMP1;PTGS2;IL1RN;MMP9;MMP2;PLAU;PCLAF;TIMP1;Tnf;COX1;Il6;Tgfb1;Ptgs2;Nos2;COX2;Il1b;Nfkb1;Ptgds;Alox5;Serpinb1-ps1 No 121 AGE-RAGE signaling pathway in diabetic complications;Acute myeloid leukemia;Adipocytokine signaling pathway;African trypanosomiasis;Allograft rejection;Alzheimer disease;Amoebiasis;Apelin signaling pathway;Apoptosis;Arachidonic acid metabolism;Bladder cancer;Breast cancer;C-type lectin receptor signaling pathway;Cell adhesion molecules;Cellular senescence;Chagas disease;Chemical carcinogenesis;Chemokine signaling pathway;Chronic myeloid leukemia;Cocaine addiction;Colorectal cancer;Complement and coagulation cascades;Coronavirus disease;Cytokine-cytokine receptor interaction;Cytosolic DNA-sensing pathway;Diabetic cardiomyopathy;Endometrial cancer;Epstein-Barr virus infection;Estrogen signaling pathway;Fluid shear stress and atherosclerosis;Focal adhesion;FoxO signaling pathway;Gastric cancer;Glioma;Graft-versus-host disease;HIF-1 signaling pathway;Hematopoietic cell lineage;Hepatitis B;Hepatitis C;Hepatocellular carcinoma;Hippo signaling pathway;Human T-cell leukemia virus 1 infection;Human cytomegalovirus infection;Human papillomavirus infection;Hypertrophic cardiomyopathy;IL-17 signaling pathway;Inflammatory bowel disease;Inflammatory mediator regulation of TRP channels;Influenza A;Insulin resistance;Intestinal immune network for IgA production;JAK-STAT signaling pathway;Kaposi sarcoma-associated herpesvirus infection;Legionellosis;Leishmaniasis;Leukocyte transendothelial migration;Lipid and atherosclerosis;Longevity regulating pathway;MAPK signaling pathway;Malaria;Measles;Melanoma;MicroRNAs in cancer;NF-kappa B signaling pathway;NOD-like receptor signaling pathway;Natural killer cell mediated cytotoxicity;Necroptosis;Neuroactive ligand-receptor interaction;Neutrophil extracellular trap formation;Non-alcoholic fatty liver disease;Non-small cell lung cancer;Osteoclast differentiation;Ovarian steroidogenesis;Oxytocin signaling pathway;PD-L1 expression and PD-1 checkpoint pathway in cancer;PI3K-Akt signaling pathway;Pancreatic cancer;Pathogenic Escherichia coli infection;Pathways in cancer;Pathways of neurodegeneration;Pertussis;Phagosome;Phospholipase D signaling pathway;Prion disease;Prolactin signaling pathway;Prostate cancer;Proteoglycans in cancer;RIG-I-like receptor signaling pathway;Rap1 signaling pathway;Ras signaling pathway;Regulation of actin cytoskeleton;Regulation of lipolysis in adipocytes;Relaxin signaling pathway;Renal cell carcinoma;Renin secretion;Renin-angiotensin system;Rheumatoid arthritis;Salmonella infection;Serotonergic synapse;Shigellosis;Small cell lung cancer;Sphingolipid signaling pathway;Staphylococcus aureus infection;Systemic lupus erythematosus;T cell receptor signaling pathway;TGF-beta signaling pathway;TNF signaling pathway;Th1 and Th2 cell differentiation;Th17 cell differentiation;Thyroid cancer;Toll-like receptor signaling pathway;Toxoplasmosis;Transcriptional misregulation in cancer;Tuberculosis;Type I diabetes mellitus;Type II diabetes mellitus;Vascular smooth muscle contraction;Viral protein interaction with cytokine and cytokine receptor;Yersinia infection;cAMP signaling pathway;cGMP-PKG signaling pathway PTGS2 1 2705 27 COX2|F2|MMP1|PCLAF|Nos2|Ptgds|PTGS2|MMP2|IL1A|BDNF|Alox5|Serpinb1-ps1|COX1|AGT|AVP|TIMP1|Nfkb1|Il6|IL1RN|FCGR3A|PLAU|MMP9|SELL|MPO|Tnf|Il1b|Tgfb1|Ptgs2 15 Eosinophilia|lung disorder|pustulosis palmaris et plantaris|osteoarthritis|systemic lupus erythematosus|respiratory failure|hypertensive disorder|Airway Obstruction|arthritic joint disease|kidney disorder|status asthmaticus|diabetes mellitus|skin disorder|drug allergy|rheumatoid arthritis
DrugBank:DB00806 PENTOXIFYLLINE 0.00412 64 0.836 3 FPR1;CRP;Tnf No 80 AGE-RAGE signaling pathway in diabetic complications;Adipocytokine signaling pathway;African trypanosomiasis;Allograft rejection;Amoebiasis;Antigen processing and presentation;Apoptosis;C-type lectin receptor signaling pathway;Chagas disease;Colorectal cancer;Complement and coagulation cascades;Coronavirus disease;Cytokine-cytokine receptor interaction;Diabetic cardiomyopathy;Epstein-Barr virus infection;Fc epsilon RI signaling pathway;Fluid shear stress and atherosclerosis;Focal adhesion;Graft-versus-host disease;HIF-1 signaling pathway;Hematopoietic cell lineage;Hepatitis B;Human T-cell leukemia virus 1 infection;Human cytomegalovirus infection;Human immunodeficiency virus 1 infection;Human papillomavirus infection;Hypertrophic cardiomyopathy;IL-17 signaling pathway;Inflammatory bowel disease;Influenza A;JAK-STAT signaling pathway;Kaposi sarcoma-associated herpesvirus infection;Legionellosis;Leishmaniasis;Leukocyte transendothelial migration;Lipid and atherosclerosis;MAPK signaling pathway;Malaria;Measles;Mitophagy;NF-kappa B signaling pathway;NOD-like receptor signaling pathway;Natural killer cell mediated cytotoxicity;Necroptosis;Neuroactive ligand-receptor interaction;Neurotrophin signaling pathway;Neutrophil extracellular trap formation;Non-alcoholic fatty liver disease;Osteoclast differentiation;PI3K-Akt signaling pathway;Pancreatic cancer;Pathogenic Escherichia coli infection;Pathways in cancer;Pertussis;Proteoglycans in cancer;RIG-I-like receptor signaling pathway;Rap1 signaling pathway;Regulation of lipolysis in adipocytes;Relaxin signaling pathway;Renal cell carcinoma;Renin secretion;Rheumatoid arthritis;Salmonella infection;Shigellosis;Sphingolipid signaling pathway;Staphylococcus aureus infection;T cell receptor signaling pathway;TGF-beta signaling pathway;TNF signaling pathway;Th1 and Th2 cell differentiation;Th17 cell differentiation;Toll-like receptor signaling pathway;Toxoplasmosis;Tuberculosis;Type I diabetes mellitus;Type II diabetes mellitus;Viral myocarditis;Yersinia infection;cAMP signaling pathway;cGMP-PKG signaling pathway CRP 1 1885 3 Tnf|CRP|FPR1 17 Fibrosis|endometriosis|pulmonary fibrosis|breast neoplasm|lung disorder|pustulosis palmaris et plantaris|diabetes mellitus|atherosclerosis|systemic sclerosis|Sepsis|vascular disorder|myocardial infarction|arthritic joint disease|kidney disorder|lung neoplasm|ischemic disease|rheumatoid arthritis
DrugBank:DB06151 ACETYLCYSTEINE 0.00431 67 0.835 9 AGT;FPR1;IL1A;PTGS2;CRP;MMP9;Tnf;Ptgs2;Nfkb1 No 129 AGE-RAGE signaling pathway in diabetic complications;AMPK signaling pathway;Acute myeloid leukemia;Adipocytokine signaling pathway;African trypanosomiasis;Allograft rejection;Alzheimer disease;Amoebiasis;Antigen processing and presentation;Apoptosis;Asthma;Autophagy;B cell receptor signaling pathway;Bladder cancer;Breast cancer;C-type lectin receptor signaling pathway;Cellular senescence;Central carbon metabolism in cancer;Chagas disease;Chemical carcinogenesis;Chemokine signaling pathway;Chronic myeloid leukemia;Cocaine addiction;Colorectal cancer;Coronavirus disease;Cytokine-cytokine receptor interaction;Cytosolic DNA-sensing pathway;Diabetic cardiomyopathy;Endometrial cancer;Epstein-Barr virus infection;Estrogen signaling pathway;Fc epsilon RI signaling pathway;Fluid shear stress and atherosclerosis;Focal adhesion;FoxO signaling pathway;Gastric cancer;Glioma;Graft-versus-host disease;Growth hormone synthesis, secretion and action;HIF-1 signaling pathway;Hematopoietic cell lineage;Hepatitis B;Hepatitis C;Hepatocellular carcinoma;Herpes simplex virus 1 infection;Human T-cell leukemia virus 1 infection;Human cytomegalovirus infection;Human immunodeficiency virus 1 infection;Human papillomavirus infection;Hypertrophic cardiomyopathy;IL-17 signaling pathway;Inflammatory bowel disease;Inflammatory mediator regulation of TRP channels;Influenza A;Insulin resistance;Intestinal immune network for IgA production;JAK-STAT signaling pathway;Kaposi sarcoma-associated herpesvirus infection;Legionellosis;Leishmaniasis;Leukocyte transendothelial migration;Lipid and atherosclerosis;Long-term depression;Longevity regulating pathway;MAPK signaling pathway;Malaria;Measles;Melanoma;MicroRNAs in cancer;Mitophagy;NF-kappa B signaling pathway;NOD-like receptor signaling pathway;Natural killer cell mediated cytotoxicity;Necroptosis;Neuroactive ligand-receptor interaction;Neurotrophin signaling pathway;Neutrophil extracellular trap formation;Non-alcoholic fatty liver disease;Non-small cell lung cancer;Osteoclast differentiation;Ovarian steroidogenesis;Oxytocin signaling pathway;PD-L1 expression and PD-1 checkpoint pathway in cancer;PI3K-Akt signaling pathway;Pancreatic cancer;Pathogenic Escherichia coli infection;Pathways in cancer;Pathways of neurodegeneration;Pertussis;Phospholipase D signaling pathway;Platelet activation;Prion disease;Prolactin signaling pathway;Prostate cancer;Proteoglycans in cancer;RIG-I-like receptor signaling pathway;Rap1 signaling pathway;Ras signaling pathway;Regulation of lipolysis in adipocytes;Relaxin signaling pathway;Renal cell carcinoma;Rheumatoid arthritis;Salmonella infection;Serotonergic synapse;Shigellosis;Signaling pathways regulating pluripotency of stem cells;Small cell lung cancer;Sphingolipid signaling pathway;Systemic lupus erythematosus;T cell receptor signaling pathway;TNF signaling pathway;Th1 and Th2 cell differentiation;Th17 cell differentiation;Thyroid cancer;Thyroid hormone signaling pathway;Toll-like receptor signaling pathway;Toxoplasmosis;Transcriptional misregulation in cancer;Tuberculosis;Type I diabetes mellitus;Type II diabetes mellitus;VEGF signaling pathway;Viral carcinogenesis;Viral myocarditis;Viral protein interaction with cytokine and cytokine receptor;Yersinia infection;cAMP signaling pathway;mTOR signaling pathway;p53 signaling pathway MMP9 1 310 10 COX2|MMP9|Ptgs2|IGF1R|Tnf|AGT|CRP|PTGS2|Nfkb1|IL1A|FPR1 10 pulmonary fibrosis|lung disorder|pneumonia|systemic sclerosis|myocardial infarction|chronic kidney disease|chronic obstructive pulmonary disease|brain disorder|lung neoplasm|systemic lupus erythematosus
DrugBank:DB00813 FENTANYL 0.00482 75 0.833 1 AVP No 45 AGE-RAGE signaling pathway in diabetic complications;Acute myeloid leukemia;Amoebiasis;Cell adhesion molecules;Cellular senescence;Chagas disease;Chemical carcinogenesis;Complement and coagulation cascades;Coronavirus disease;Cytokine-cytokine receptor interaction;Cytosolic DNA-sensing pathway;Fc gamma R-mediated phagocytosis;HIF-1 signaling pathway;Hematopoietic cell lineage;Hepatitis B;Hypertrophic cardiomyopathy;IL-17 signaling pathway;Inflammatory bowel disease;Influenza A;JAK-STAT signaling pathway;Kaposi sarcoma-associated herpesvirus infection;Legionellosis;Leishmaniasis;Malaria;Natural killer cell mediated cytotoxicity;Neuroactive ligand-receptor interaction;Neutrophil extracellular trap formation;Non-alcoholic fatty liver disease;Osteoclast differentiation;Pathways in cancer;Pertussis;Phagosome;Phospholipase D signaling pathway;RIG-I-like receptor signaling pathway;Rheumatoid arthritis;Staphylococcus aureus infection;Systemic lupus erythematosus;TNF signaling pathway;Th17 cell differentiation;Toll-like receptor signaling pathway;Transcriptional misregulation in cancer;Tuberculosis;Vascular smooth muscle contraction;Viral protein interaction with cytokine and cytokine receptor;Yersinia infection ITGAM 1 2795 4 ITGAM|FCGR3A|MPO|AVP 9 Inflammation|breast neoplasm|osteoarthritis|heart disorder|myocardial infarction|hypertensive disorder|kidney disorder|lung neoplasm|rheumatoid arthritis
DrugBank:DB03128 ACETYLCHOLINE 0.00495 77 0.832 11 BDNF;AGT;AVP;NOS1;MYH14;MBP;KCNMB2;CA2;Apoe;Vip;Tac1 No 84 AGE-RAGE signaling pathway in diabetic complications;African trypanosomiasis;Allograft rejection;Alzheimer disease;Amoebiasis;Apelin signaling pathway;Apoptosis;Arginine and proline metabolism;Arginine biosynthesis;Autophagy;C-type lectin receptor signaling pathway;Chagas disease;Chemical carcinogenesis;Coronavirus disease;Diabetic cardiomyopathy;Fc epsilon RI signaling pathway;Fc gamma R-mediated phagocytosis;Fluid shear stress and atherosclerosis;Graft-versus-host disease;Growth hormone synthesis, secretion and action;HIF-1 signaling pathway;Hepatitis B;Human cytomegalovirus infection;Human immunodeficiency virus 1 infection;Hypertrophic cardiomyopathy;IL-17 signaling pathway;Inflammatory bowel disease;Inflammatory mediator regulation of TRP channels;Influenza A;Insulin resistance;Legionellosis;Leishmaniasis;Lipid and atherosclerosis;Long-term depression;MAPK signaling pathway;Malaria;Measles;NF-kappa B signaling pathway;NOD-like receptor signaling pathway;Natural killer cell mediated cytotoxicity;Necroptosis;Neuroactive ligand-receptor interaction;Neurotrophin signaling pathway;Neutrophil extracellular trap formation;Non-alcoholic fatty liver disease;Osteoclast differentiation;Ovarian steroidogenesis;Oxytocin signaling pathway;PI3K-Akt signaling pathway;Pathogenic Escherichia coli infection;Pathways in cancer;Pathways of neurodegeneration;Pertussis;Phagosome;Phospholipase D signaling pathway;Platelet activation;Prion disease;Proteoglycans in cancer;Rap1 signaling pathway;Ras signaling pathway;Regulation of actin cytoskeleton;Regulation of lipolysis in adipocytes;Relaxin signaling pathway;Renin secretion;Renin-angiotensin system;Rheumatoid arthritis;Salmonella infection;Serotonergic synapse;Shigellosis;Sphingolipid signaling pathway;T cell receptor signaling pathway;TNF signaling pathway;Th17 cell differentiation;Toll-like receptor signaling pathway;Toxoplasmosis;Tuberculosis;Type I diabetes mellitus;Type II diabetes mellitus;VEGF signaling pathway;Vascular smooth muscle contraction;Yersinia infection;cAMP signaling pathway;cGMP-PKG signaling pathway;mTOR signaling pathway AGT 1 402 11 MBP|Tac1|Vip|F2|MYH14|AGT|CA2|NOS1|AVP|Apoe|BDNF|KCNMB2 10 heart disorder|vascular disorder|myocardial infarction|respiratory failure|hypertensive disorder|chronic obstructive pulmonary disease|diabetes mellitus|Dermatitis, Atopic|ischemic disease|rheumatoid arthritis
DrugBank:DB03843 FORMALDEHYDE 0.00514 80 0.832 3 Trpv1;Serpinb1-ps1;Tac1 No 11 Apoptosis;Breast cancer;Colorectal cancer;Complement and coagulation cascades;Fluid shear stress and atherosclerosis;Inflammatory mediator regulation of TRP channels;Measles;MicroRNAs in cancer;Neuroactive ligand-receptor interaction;Pathways in cancer;Pertussis Trpv1 1 102 3 Serpinb1-ps1|Trpv1|Tac1 3 diabetes mellitus|Dermatitis, Atopic|allergic disease
DrugBank:DB00755 TRETINOIN 0.00547 85 0.829 23 CCND1;BDNF;FOXO3;CD8A;IL1A;VIP;MMP1;NOS1;ARG1;IFNA1;MMP9;MMP2;PLAU;IGFBP3;KLF4;TIMP1;KCNMB2;TNFAIP3;Tnf;FOXP3;Il6;Tgfb1;Il23a No 137 AGE-RAGE signaling pathway in diabetic complications;AMPK signaling pathway;Acute myeloid leukemia;Adipocytokine signaling pathway;African trypanosomiasis;Allograft rejection;Alzheimer disease;Amoebiasis;Antigen processing and presentation;Apelin signaling pathway;Apoptosis;Arachidonic acid metabolism;Arginine and proline metabolism;Asthma;Autoimmune thyroid disease;Autophagy;Axon guidance;B cell receptor signaling pathway;Bladder cancer;Breast cancer;C-type lectin receptor signaling pathway;Cellular senescence;Central carbon metabolism in cancer;Chagas disease;Chemical carcinogenesis;Chemokine signaling pathway;Chronic myeloid leukemia;Cocaine addiction;Colorectal cancer;Complement and coagulation cascades;Coronavirus disease;Cytokine-cytokine receptor interaction;Cytosolic DNA-sensing pathway;Diabetic cardiomyopathy;Endometrial cancer;Epstein-Barr virus infection;Estrogen signaling pathway;Fc epsilon RI signaling pathway;Fluid shear stress and atherosclerosis;Focal adhesion;FoxO signaling pathway;Gastric cancer;Glioma;Graft-versus-host disease;Growth hormone synthesis, secretion and action;HIF-1 signaling pathway;Hematopoietic cell lineage;Hepatitis B;Hepatitis C;Hepatocellular carcinoma;Herpes simplex virus 1 infection;Hippo signaling pathway;Human T-cell leukemia virus 1 infection;Human cytomegalovirus infection;Human immunodeficiency virus 1 infection;Human papillomavirus infection;Hypertrophic cardiomyopathy;IL-17 signaling pathway;Inflammatory bowel disease;Inflammatory mediator regulation of TRP channels;Influenza A;Insulin resistance;Intestinal immune network for IgA production;JAK-STAT signaling pathway;Kaposi sarcoma-associated herpesvirus infection;Legionellosis;Leishmaniasis;Leukocyte transendothelial migration;Lipid and atherosclerosis;Long-term depression;Longevity regulating pathway;MAPK signaling pathway;Malaria;Measles;Melanoma;MicroRNAs in cancer;Mitophagy;NF-kappa B signaling pathway;NOD-like receptor signaling pathway;Natural killer cell mediated cytotoxicity;Necroptosis;Neurotrophin signaling pathway;Neutrophil extracellular trap formation;Non-alcoholic fatty liver disease;Non-small cell lung cancer;Osteoclast differentiation;Ovarian steroidogenesis;Oxytocin signaling pathway;PD-L1 expression and PD-1 checkpoint pathway in cancer;PI3K-Akt signaling pathway;Pancreatic cancer;Pathogenic Escherichia coli infection;Pathways in cancer;Pathways of neurodegeneration;Pertussis;Phagosome;Phospholipase D signaling pathway;Prion disease;Prolactin signaling pathway;Prostate cancer;Proteoglycans in cancer;RIG-I-like receptor signaling pathway;Rap1 signaling pathway;Ras signaling pathway;Regulation of actin cytoskeleton;Relaxin signaling pathway;Renal cell carcinoma;Renin secretion;Rheumatoid arthritis;Salmonella infection;Serotonergic synapse;Shigellosis;Signaling pathways regulating pluripotency of stem cells;Small cell lung cancer;Sphingolipid signaling pathway;T cell receptor signaling pathway;TGF-beta signaling pathway;TNF signaling pathway;Th1 and Th2 cell differentiation;Th17 cell differentiation;Thyroid cancer;Thyroid hormone signaling pathway;Toll-like receptor signaling pathway;Toxoplasmosis;Transcriptional misregulation in cancer;Tuberculosis;Type I diabetes mellitus;Type II diabetes mellitus;VEGF signaling pathway;Viral carcinogenesis;Viral myocarditis;Viral protein interaction with cytokine and cytokine receptor;Yersinia infection;cAMP signaling pathway;cGMP-PKG signaling pathway;mTOR signaling pathway;p53 signaling pathway TIMP1 1 2327 27 IGFBP3|FOXP3|MMP1|MMP2|BDNF|IL1A|TNFAIP3|ARG1|FAS|TIMP1|KLF4|Il6|IFNA1|IL1R1|Il23a|NOS1|IL10|PLAU|MMP9|VIP|FOXO3|CD8A|SMAD2|Tnf|Tgfb1|CCND1|KCNMB2 8 endometriosis|pulmonary emphysema|pustulosis palmaris et plantaris|atherosclerosis|hypertensive disorder|kidney disorder|brain disorder|lung neoplasm
DrugBank:DB12510 OZONE 0.00630 98 0.823 3 Tnf;Il17a;Il6 No 57 AGE-RAGE signaling pathway in diabetic complications;Adipocytokine signaling pathway;African trypanosomiasis;Allograft rejection;Alzheimer disease;Amoebiasis;Asthma;Bladder cancer;C-type lectin receptor signaling pathway;Cellular senescence;Chagas disease;Coronavirus disease;Cytokine-cytokine receptor interaction;Epstein-Barr virus infection;Fluid shear stress and atherosclerosis;FoxO signaling pathway;Graft-versus-host disease;HIF-1 signaling pathway;Hematopoietic cell lineage;Hepatitis B;Herpes simplex virus 1 infection;Human T-cell leukemia virus 1 infection;Human cytomegalovirus infection;Hypertrophic cardiomyopathy;IL-17 signaling pathway;Inflammatory bowel disease;Influenza A;Insulin resistance;Intestinal immune network for IgA production;Kaposi sarcoma-associated herpesvirus infection;Legionellosis;Lipid and atherosclerosis;MAPK signaling pathway;Malaria;NF-kappa B signaling pathway;NOD-like receptor signaling pathway;Non-alcoholic fatty liver disease;PI3K-Akt signaling pathway;Pathogenic Escherichia coli infection;Pathways in cancer;Pathways of neurodegeneration;Pertussis;Prion disease;RIG-I-like receptor signaling pathway;Rheumatoid arthritis;Salmonella infection;Shigellosis;Systemic lupus erythematosus;TNF signaling pathway;Th17 cell differentiation;Toll-like receptor signaling pathway;Transcriptional misregulation in cancer;Tuberculosis;Type I diabetes mellitus;Type II diabetes mellitus;Viral protein interaction with cytokine and cytokine receptor;Yersinia infection Il6 1 95 3 Tnf|Il6|Il17a 12 pulmonary emphysema|brain disorder|osteoarthritis|atherosclerosis|drug allergy|vascular disorder|hypertensive disorder|status asthmaticus|diabetes mellitus|Dermatitis, Atopic|ischemic disease|rheumatoid arthritis
MESH:D005227 Fatty Acids 0.00637 99 0.823 11 IL1A;PTGS2;NAMPT;CRP;ADIPOQ;Tnf;CAMP;Nos2;Lep;Pparg;Adipoq No 76 AGE-RAGE signaling pathway in diabetic complications;AMPK signaling pathway;Adipocytokine signaling pathway;African trypanosomiasis;Alzheimer disease;Amoebiasis;Apelin signaling pathway;Arachidonic acid metabolism;Arginine biosynthesis;C-type lectin receptor signaling pathway;Cellular senescence;Chagas disease;Chemical carcinogenesis;Complement and coagulation cascades;Coronavirus disease;Cytokine-cytokine receptor interaction;Diabetic cardiomyopathy;Fluid shear stress and atherosclerosis;FoxO signaling pathway;Graft-versus-host disease;Growth hormone synthesis, secretion and action;HIF-1 signaling pathway;Hematopoietic cell lineage;Hepatitis B;Hepatitis C;Human T-cell leukemia virus 1 infection;Human cytomegalovirus infection;Hypertrophic cardiomyopathy;IL-17 signaling pathway;Inflammatory bowel disease;Inflammatory mediator regulation of TRP channels;Influenza A;Insulin resistance;Kaposi sarcoma-associated herpesvirus infection;Legionellosis;Leishmaniasis;Lipid and atherosclerosis;Longevity regulating pathway;MAPK signaling pathway;Malaria;Measles;Melanoma;NF-kappa B signaling pathway;NOD-like receptor signaling pathway;Necroptosis;Neuroactive ligand-receptor interaction;Neutrophil extracellular trap formation;Non-alcoholic fatty liver disease;Osteoclast differentiation;Ovarian steroidogenesis;PD-L1 expression and PD-1 checkpoint pathway in cancer;PI3K-Akt signaling pathway;Pathogenic Escherichia coli infection;Pathways in cancer;Pathways of neurodegeneration;Pertussis;Prion disease;Prostate cancer;Ras signaling pathway;Regulation of lipolysis in adipocytes;Rheumatoid arthritis;Salmonella infection;Shigellosis;Small cell lung cancer;TNF signaling pathway;Toll-like receptor signaling pathway;Toxoplasmosis;Transcriptional misregulation in cancer;Tuberculosis;Type I diabetes mellitus;Type II diabetes mellitus;Viral protein interaction with cytokine and cytokine receptor;Yersinia infection;cAMP signaling pathway;mTOR signaling pathway;p53 signaling pathway PTGS2 1 268 11 COX2|Pparg|NAMPT|ADIPOQ|Adipoq|Tnf|Nos2|CRP|PTGS2|Lep|CAMP|IL1A 15 Fibrosis|systemic lupus erythematosus|heart disorder|myocardial infarction|respiratory failure|hypertensive disorder|arthritic joint disease|kidney disorder|chronic obstructive pulmonary disease|diabetes mellitus|ulcerative colitis|Dermatitis, Atopic|ischemic disease|colitis|rheumatoid arthritis

Prompt for ChatGPT Deep Research

你是一个医学与药理学领域的专家,精通药物的化学成分、作用机制、分类标准及其在临床和基础研究中的应用。请基于以下药物的名称:

['NICOTINE', 'NOREPINEPHRINE', 'Prostaglandins', 'ALDOSTERONE', 'IBUPROFEN', 'INDOMETHACIN', 'PENTOXIFYLLINE', 'ACETYLCYSTEINE', 'FENTANYL', 'ACETYLCHOLINE', 'FORMALDEHYDE', 'TRETINOIN', 'OZONE', 'Fatty Acids']

为我完成如下任务,所有输出必须以**中文**呈现,并包括**结构化表格**:

#### ✅ **任务要求如下:**

1. **药物基本信息表:**

   * 药物英文名
   * 药物中文名
   * 作用机制(详细)
   * 药理分类(基于作用机制)

2. **药物对 asthma 的影响分析:**

   * 每种药物提供至少**一篇权威文献(PubMed 优先)**
   * 每篇文献需包含:

     * 文献标题
     * PMID(PubMed ID)
     * 研究类型(基础/临床/综述等)
     * 实验模型(如有)
     * 主要发现/结论(特别强调药物对 asthma 的影响)

3. **输出格式要求:**

   * 所有内容用**表格**清晰列出
   * 药理分类需以机制为核心,如“酪氨酸激酶抑制剂”“抗生素类”“能量代谢调节剂”等,并给出具体分类
   * 文献结论部分用**准确、简明的中文表述**

### 示例输出格式(供参考):

#### 表1:药物基本信息与分类

| 药物英文名 | 中文名     | 作用机制说明                                            | 药理分类                   |
| ---------- | ---------- | ------------------------------------------------------- | -------------------------- |
| Nintedanib | 尼达尼布   | 抑制VEGFR、FGFR、PDGFR等酪氨酸激酶,阻断纤维化信号通路  | 抗纤维化类酪氨酸激酶抑制剂 |
| Rifampin   | 利福平     | 抑制细菌RNA聚合酶,阻断转录过程                         | 抗生素(抗结核药)         |
| ATP        | 三磷酸腺苷 | 提供能量,参与信号传导,可作用于P2X/P2Y受体调节细胞活性 | 能量代谢与信号调节剂       |

#### 表2:药物对Scarring影响的研究文献

| 药物英文名 | 文献标题 | PMID | 研究类型 | 模型             | 主要结论                                |
| ---------- | -------- | ---- | -------- | ---------------- | --------------------------------------- |
| Nintedanib | ...      | ...  | 临床试验 | IPF患者          | 显著减少肺部纤维化,有望用于抗瘢痕治疗  |
| Rifampin   | ...      | ...  | 动物实验 | 大鼠皮肤创伤模型 | 可减少成纤维细胞增殖,有抗瘢痕潜力      |
| ATP        | ...      | ...  | 细胞实验 | 人皮肤成纤维细胞 | ATP调节成纤维细胞迁移,可能影响瘢痕修复 |
Interpretation:

📈 Visualization Analysis

Drug Predicted Score Distribution

Interpretation:

Predicted Score Distribution by Knowledge Graph Inclusion

Interpretation:

Drug Similarity Heatmap

Interpretation:

Network Centrality Analysis

Chart
Interpretation:

Shared Genes and Pathways Analysis

Chart
Interpretation:

Drug Similarity Network

Chart
Interpretation:

Number of Shared Genes Between Drugs and Diseases

Chart
Interpretation:

Drug Degree vs Predicted Score

Chart
Interpretation:

Shared Gene Count vs Predicted Score

Interpretation:

Number of Overlapping Pathways Between Drugs and Diseases

Chart
Interpretation:

Number of Key Genes Distribution

Chart
Interpretation:

Ratio of Known Drugs to Predicted Drugs

Chart
Interpretation:

💡 Analysis Conclusion

Main Findings:

  • The model successfully identified multiple candidate drugs, including known therapeutic drugs, verifying the effectiveness of the method.
  • High-scoring drugs have higher network centrality and shared gene numbers, which is consistent with biological principles.
  • Predicted drugs are similar to known drugs in multiple feature dimensions, supporting their potential therapeutic value.

Suggestions:

  • Prioritize the top 10 high-scoring drugs for experimental validation.
  • Focus on drugs with high shared gene numbers and overlapping pathways.
  • Combine network centrality analysis to select drugs with strong regulatory capabilities.

Report Generation Time: 2025-07-04 16:37:37

Powered by drugs4disease